Holobeam Technologies has filed a notice of an exempt offering of securities to raise $16,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Holobeam Technologies is raising up to $16,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Gene Dolgoff played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Holobeam Technologies
Using theranostic scanners, we teleport energy to proprietary nanoparticles, which destroys viruses or diseased cells (yet do no harm). We are a laser-focused team that’s working on bringing life-changing solutions to patients. We have successfully treated cancer in mice and dogs and are diligently working towards getting our diagnosis and treatment protocols and equipment to market for pets and people. Find out how you can support us in our effort.
To learn more about Holobeam Technologies, visit http://www.holobeamtech.com/
Contact:
Gene Dolgoff, Chief Executive Officer
516-338-5000
https://www.linkedin.com/in/genedolgoff/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.